Star Combo Pharma Ltd
ASX:S66

Watchlist Manager
Star Combo Pharma Ltd Logo
Star Combo Pharma Ltd
ASX:S66
Watchlist
Price: 0.12 AUD 9.09% Market Closed
Market Cap: 16.2m AUD
Have any thoughts about
Star Combo Pharma Ltd?
Write Note

Star Combo Pharma Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Star Combo Pharma Ltd
Cash Equivalents Peer Comparison

Comparables:
BXN
MCP
EXL
B
BIO
H
HPC

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Star Combo Pharma Ltd
ASX:S66
Cash Equivalents
AU$7.4m
CAGR 3-Years
-25%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Bioxyne Ltd
ASX:BXN
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
McPherson's Ltd
ASX:MCP
Cash Equivalents
AU$24.8m
CAGR 3-Years
50%
CAGR 5-Years
19%
CAGR 10-Years
20%
Elixinol Wellness Ltd
ASX:EXL
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Biome Australia Ltd
ASX:BIO
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hydration Pharmaceuticals Co Ltd
ASX:HPC
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Star Combo Pharma Ltd's Cash Equivalents?
Cash Equivalents
7.4m AUD

Based on the financial report for Jun 30, 2024, Star Combo Pharma Ltd's Cash Equivalents amounts to 7.4m AUD.

What is Star Combo Pharma Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
10%

Over the last year, the Cash Equivalents growth was -22%. The average annual Cash Equivalents growth rates for Star Combo Pharma Ltd have been -25% over the past three years , 10% over the past five years .

Back to Top